IRS1 and breast carcinoma: Yet Mukohara et al. could demonstrate that in their investigated breast cancer cell lines the expression of IRS-1 (insulin receptor substrate 1) correlates with the response to AEW541, identifying IRS-1 expression of a marker for AEW541 efficacy independent of IGF-1R expression [68].